Maxcyte (MXCT) Research & Development (2020 - 2026)
Maxcyte (MXCT) posted quarterly Research & Development of $3.9 million for Q1 2026, down 34.66% year-over-year from $5.9 million in Q1 2025, and up 10.07% quarter-over-quarter from $3.5 million in Q4 2025.
Maxcyte (MXCT) Research & Development (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Research & Development for 7 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 34.66% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $18.9 million (down 4.67% YoY), while the FY2025 annual figure was $18.9 million, down 14.86% from the prior year.
- Research & Development climbed to $3.9 million in Q1 2026 per MXCT's latest filing, from $3.5 million in the prior quarter.
- Across five years, Research & Development topped out at $7.4 million in Q1 2024 and bottomed at $2.0 million in Q4 2024.
- Historically, Research & Development has averaged $5.2 million across 5 years, with a median of $5.3 million in 2022.
- Annual changes were most pronounced in 2022 — Research & Development surged 487.02% — and 2024, when it plunged 49.52%.
- Maxcyte's Research & Development stood at $5.7 million in 2022, then dropped by 29.48% to $4.0 million in 2023, then slumped by 49.52% to $2.0 million in 2024, then surged by 71.85% to $3.5 million in 2025, then gained by 10.07% to $3.9 million in 2026.
- Business Quant data shows MXCT's Research & Development at $3.9 million in Q1 2026, $3.5 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Maxcyte | 146.88 Mn | 146.88 Mn | 5.60 Mn | 4.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.25 Mn |
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 6.27 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 6.62 Mn |
| Mar 31, 2024 | 7.37 Mn |
| Dec 31, 2023 | 4.04 Mn |
| Sep 30, 2023 | 7.05 Mn |
| Jun 30, 2023 | 5.66 Mn |
| Mar 31, 2023 | 6.05 Mn |
| Dec 31, 2022 | 5.73 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Jun 30, 2022 | 4.93 Mn |
| Mar 31, 2022 | 3.84 Mn |
| Dec 31, 2021 | 975,700.00 |
| Sep 30, 2021 | 3.21 Mn |